R. Slepon

1.4k citations
38 papers · 1.1k indexed · h-index 17

Impact in

    • Escherichia coli research studies
    • Vibrio bacteria research studies
    • Viral gastroenteritis research and epidemiology
    • Clostridium difficile and Clostridium perfringens research
    • Viral Infections and Vectors

Papers in

    • Escherichia coli research studies 10
    • Hepatitis Viruses Studies and Epidemiology 8
    • Hepatitis C virus research 4

R. Slepon

38 papers receiving 1.0k citations

Peers

R. Slepon
Comparison fields: 5 of 91
  • Endocrinology 476
  • Infectious Diseases 651
  • Hepatology 163
  • Microbiology 58
  • Parasitology 47
Replace Kawsar R. Talaat with:
Kawsar R. Talaat United States
Andrew F. Trofa United States
Remon Abu‐Elyazeed United States
S D Sears United States
Fariba Keramat Iran
Julia Lynch United States
Manivanh Vongsouvath Laos
Salwa F. Ahmed Egypt
A.‐M. Svennerholm Sweden
Gaia Scavia Italy
R. Slepon relative to Kawsar R. Talaat United States Kawsar R. Talaat's profile →
Citations per field
00.5×3.8×
Kawsar R. Talaat · 1×
Citations per year

Countries citing papers authored by R. Slepon

Since Specialization
Citations

This map shows the geographic impact of R. Slepon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Slepon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Slepon more than expected).

Fields of papers citing papers by R. Slepon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Slepon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Slepon. The network helps show where R. Slepon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside R. Slepon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Slepon Line = papers co-authored together R. Slepon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20028
2 200122
3 200122
4 200020
5 1997199
6 199733
7 19964
8 19964
9 199416
10 199417
11 199466
12 19946
13
Clinical, serological and molecular characteristics of 471 hepatitis B virus carriers.
19941
14 19942
15 199320
16 199229
17 19911
18 199112
19 199114
20 199012

About R. Slepon

R. Slepon is a scholar working on Endocrinology, Hepatology, Infectious Diseases, Health and Epidemiology, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (10 papers), Escherichia coli research studies (10 papers), Hepatitis Viruses Studies and Epidemiology (8 papers), Hepatitis B Virus Studies (7 papers), Virology and Viral Diseases (5 papers), Clostridium difficile and Clostridium perfringens research (5 papers), Vaccine Coverage and Hesitancy (5 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Endocrinology (476 citations), Infectious Diseases (651 citations), Hepatology (163 citations), Microbiology (58 citations) and Parasitology (47 citations). R. Slepon has collaborated with scholars based in Israel, United States and Sweden. Frequent co-authors include Manfred S. Green, Dani Cohen, Colin Block, Guy Robin, Nadav Orr, Shai Ashkenazi, Ruhama Ambar, Itzhak Ofek, Yehuda Lerman and Steven S. Wasserman. Their work appears in journals such as International Journal of Epidemiology, Vaccine, Infection and Immunity, Infection and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026